SARS-CoV-2 management in Emergency Department: risk stratification and care setting identification proposal based on first pandemic wave in Pisa University Hospital

Submitted: 16 May 2021
Accepted: 29 November 2021
Published: 20 December 2021
Abstract Views: 2353
PDF: 294
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

SARS-CoV-2 management in Emergency Department: risk stratification and care setting identification proposal based on first pandemic wave in Pisa University Hospital

Background: COVID-19 patients require early treatment and admission to an appropriate care setting, considering possible rapid and unpredictable to Severe Acute Respiratory Syndrome.

Objective: A flow-chart was developed by a multidisciplinary team of Emergency Department (ED) clinicians, intensivists and radiologists aiming to provide tools for disease severity stratification, appropriate ventilation strategy and hospitalization setting identification.

Methods: We conducted a retrospective application of our model on 313 hospitalized patients at Pisa University Hospital including 222 patients admitted to ED for respiratory failure between March and April 2020. Risk stratification score was based on respiratory and chest imaging parameters, while management strategy on comorbidities and age. 

Results: Age, comorbidities, clinical respiratory and arterial blood gas parameters, semi-quantitative chest computed tomography score were significant predictors of mortality (p<0,05). Mortality rate was higher in patients treated in intensive care units (26,5%) and undergoing endo-tracheal intubation (32,7%), compared to medical area (21,3%). We verified a good concordance (81,7%) between the proposed model and actual evaluation in ED. Outcomes analysis of subgroups of patients homogeneous for baseline features allowed to verify safety of our model: in non-elderly and/or non-comorbid patients (15% mortality) our scheme overestimates the risk in 30% of cases, but it suggests non-intensive management in patients with reduced functional reserve, elderly and with comorbidities (50% mortality).

Conclusion: Correct management of respiratory failure COVID-19 patients is crucial in this unexpected pandemic. Our flow-chart, despite retrospectively application in small sample, could represents a valid and safe proposal for evaluation in ED.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

WHO. Clinical management of COVID-19: interim guidance. WHO: 27 May 2020. 2020. Available from: https://apps.who.int/iris/handle/10665/332196
Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382:1708-1720. DOI: https://doi.org/10.1056/NEJMoa2002032
Figliozzi S, Masci PG, Ahmadi N, et al. Predictors of adverse prognosis in COVID-19: A systematic review and meta-analysis. Eur J Clin Invest 2020;50:e13362. DOI: https://doi.org/10.1111/eci.13362
Gruppo di Studio ad Hoc della Commissione di Bioetica della SIAARTI. SIAARTI guidelines for admission to and discharge from Intensive Care Units and for limitation of treatment in intensive care. Minerva Anestesiol 2003;69:101-11, 111-18.
Di Domenico SL, Coen D, Bergamaschi M, et al. Clinical characteristics and respiratory support of 310 COVID-19 patients, diagnosed at the emergency room: a single-center retrospective study. Intern Emerg Med 2020;16:1051-60. DOI: https://doi.org/10.1007/s11739-020-02548-0
Liang W, Liang H, Ou L, et al. Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19. JAMA Intern Med 2020;180:1081-9. DOI: https://doi.org/10.1001/jamainternmed.2020.2033
Haimovich AD, Ravindra NG, Stoytchev S, et al. Development and validation of the quick COVID-19 severity index: A prognostic tool for early clinical decompensation. Ann Emerg Med 2020;76:442-53. DOI: https://doi.org/10.1016/j.annemergmed.2020.07.022
Swiss Academy Of Medical Sciences. COVID-19 pandemic: triage for intensive-care treatment under resource scarcity (3rd, updated version). Swiss Med Wkly 2020;150:w20401. DOI: https://doi.org/10.4414/smw.2020.20401
Zheng Z, Peng F, Xu B, et al. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. J Infect 2020;81:e16-e25. DOI: https://doi.org/10.1016/j.jinf.2020.04.021
Wiersinga WJ, Rhodes A, Cheng AC, et al. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): A review. JAMA 2020;324:782-93. DOI: https://doi.org/10.1001/jama.2020.12839
Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020;323:1239-42. DOI: https://doi.org/10.1001/jama.2020.2648
Cozzi D, Albanesi M, Cavigli E, et al. Chest X-ray in new Coronavirus Disease 2019 (COVID-19) infection: Findings and correlation with clinical outcome. Radiol Med 2020;125:730-7. DOI: https://doi.org/10.1007/s11547-020-01232-9
Francone M, Iafrate F, Masci GM, et al. Chest CT score in COVID-19 patients: Correlation with disease severity and short-term prognosis. Eur Radiol 2020;30:6808-6817. DOI: https://doi.org/10.1007/s00330-020-07033-y
Li K, Fang Y, Li W, et al. CT image visual quantitative evaluation and clinical classification of coronavirus disease (COVID-19). Eur Radiol 2020;30:4407-16. DOI: https://doi.org/10.1007/s00330-020-06817-6
Chung M, Bernheim A, Mei X, et al. CT imaging features of 2019 novel coronavirus (2019-nCoV). Radiology 2020;295:202-7. DOI: https://doi.org/10.1148/radiol.2020200230
Colombi D, Villani GD, Maffi G, et al. Qualitative and quantitative chest CT parameters as predictors of specific mortality in COVID-19 patients. Emerg Radiol 2020; doi:10.1007/s10140-020-01867-1 DOI: https://doi.org/10.1007/s10140-020-01867-1
Gargani L, Soliman-Aboumarie H, Volpicelli G, et al. Why, when, and how to use lung ultrasound during the COVID-19 pandemic: Enthusiasm and caution. Eur Heart J Cardiovasc Imaging 2020;21:941-8. DOI: https://doi.org/10.1093/ehjci/jeaa163
Volpicelli G, Gargani L. Sonographic signs and patterns of COVID-19 pneumonia. Ultrasound J 2020;12:22. DOI: https://doi.org/10.1186/s13089-020-00171-w
Poggiali E, Bastoni D, Ferrari M, et al. COVID-19 or not COVID-19, that is the question. The role of screening criteria and point-of-care lung ultrasound in the triage decision-making process in an Emergency Department during the phase 2 of the COVID-19 Italian epidemic. Emerg Care J 2021;17:9708. DOI: https://doi.org/10.4081/ecj.2021.9708
Dacrema A, Silva M, Rovero L, et al. A simple lung ultrasound protocol for the screening of COVID-19 pneumonia in the emergency department. Intern Emerg Med 2021;16:1297-305. DOI: https://doi.org/10.1007/s11739-020-02596-6
Barbieri G, Spinelli S, Filippi M, et al. COVID-19 pandemic management at the Emergency Department: The changing scenario at the University Hospital of Pisa. Emerg Care J 2020;16:9146. DOI: https://doi.org/10.4081/ecj.2020.9146
Knight SR, Ho A, Pius R, et al. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: Development and validation of the 4C Mortality Score. BMJ 2020;370:m3339.
Di Castelnuovo A, Bonaccio M, Costanzo S, et al. Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: Survival analysis and machine learning-based findings from the multicentre Italian CORIST Study. Nutr Metab Cardiovasc Dis 2020;30:1899-913. DOI: https://doi.org/10.1016/j.numecd.2020.07.031
Falcone M, Tiseo G, Barbieri G, et al. Role of low-molecular weight heparin in hospitalized patients with SARS-CoV-2 pneumonia: a prospective observational study. Open Forum Infectious Diseases 2020;7:ofaa563. DOI: https://doi.org/10.1093/ofid/ofaa563
Gattinoni L, Chiumello D, Caironi P, et al. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med 2020;46:1099-102. DOI: https://doi.org/10.1007/s00134-020-06033-2
Marini JJ, Gattinoni L. Management of COVID-19 respiratory distress. JAMA 2020;323:2329-30. DOI: https://doi.org/10.1001/jama.2020.6825
Corradi F, Vetrugno L, Orso D, et al. Diaphragmatic thickening fraction as a potential predictor of response to continuous positive airway pressure ventilation in Covid-19 pneumonia: A single-center pilot study. Respir Physiol Neurobiol 2020;284:103585. DOI: https://doi.org/10.1016/j.resp.2020.103585
Ferruccio Aquilini, University Hospital of Pisa

Medical Directional Department, University Hospital of Pisa

How to Cite

Barbieri, G., Cipriano, A., Carrara, S., Spinelli, S., Cinotti, F., Foltran, F., Filippi, M., Aquilini, F., Tonerini, M., Santini, M., Malacarne, P., & Ghiadoni, L. (2021). SARS-CoV-2 management in Emergency Department: risk stratification and care setting identification proposal based on first pandemic wave in Pisa University Hospital. Emergency Care Journal, 17(4). https://doi.org/10.4081/ecj.2021.9859